netFormulary NHS
North Central London
Joint Formulary
 Search
 Formulary Chapter 6: Endocrine system - Full Chapter
06.05.02  Expand sub section  Posterior pituitary hormones and antagonists
06.05.02  Expand sub section  Posterior pituitary hormones
Desmopressin
View adult BNF View SPC online View childrens BNF
Formulary
AAAAAAAA

Provider notes

  • NMUH:
    • DDAVP: On formulary
    • DesmoMelt: Formulary for use as a first line agent in the treatment of primary nocturnal enuresis
  • RFL:
    • DDAVP: Restricted to child health; sublingual tablets available (120micrograms and 240micrograms)
    • Desmotabs: Restricted to child health
    • Desmospray: On formulary
    • Octim: On formulary
    • Injection: 4micrograms in 1mL available
  • RNOH:
    • Tablets, Injection, Nasal spray (for continuation of treatment), Oral lyophilisates (for continuation of treatment)
  • UCLH:
  • WH:
    • DDAVP: Intranasal solution 100 micrograms/1 ml & Inj 4 micrograms/1 ml ONLY
    • DesmoMelt: The use of Desmomelt tablets is restricted to Paediatrics only
    • Desmotabs: The use of desmopressin tablets is restricted to Dr Rossi only
    • Desmospray: On Formulary
 
Terlipressin
View adult BNF View SPC online View childrens BNF
Formulary
GP - Red
AAAAAAAA

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • Restricted to hepatology and critical care for use in variceal bleeding and in hepato-renal syndrome only
  • RNOH:
    • Store in a refrigerator
  • UCLH:
  • WH:
    • No restriction stated
 
Argipressin
(Vasopressin, synthetic)
View adult BNF View SPC online View childrens BNF
Formulary
AAAAAAAA

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • No restriction stated
  • RNOH:
    • Store in a refrigerator
  • UCLH:
  • WH:
    • Non-formulary
 
06.05.02  Expand sub section  Antidiuretic hormone antagonists
 ....
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to children's BNF
click to search medicines.org.uk
Link to SPCs
Homecare
Homecare

Traffic Light Status Information

Status Description

GP - Amber

Medicines that should be initiated by a specialist. Prescribing can be transferred to primary care once the patient has been stabilised.  

Shared care: For drugs with regular, ongoing need for monitoring and/or assessment of efficacy or toxicity. Prior agreement must be obtained by the specialist from the primary care provider before prescribing responsibility is transferred. The shared care protocol must have been agreed by the relevant secondary care trust Drugs and Therapeutics Committee(s) (DTC) and approved by the North Central London JFC.

Fact sheet: For drugs with some concerns surrounding safety or efficacy but do not require regular monitoring and/or monitoring of effectiveness/toxicity.

  

GP - Red

Medicines which should normally be prescribed by specialists only (hospital only).

For patients already receiving prescriptions in primary care - continue. No new patients to receive prescriptions in primary care.

See link for the complete NCL Red List https://www.ncl-mon.nhs.uk/wp-content/uploads/2017/08/ncl_red_list.pdf

  

Black

Medicines not recommended for routine use in primary or secondary care.

Medicines, which the North Central London JFC has actively reviewed and does not recommend for use at present due to limited clinical and/or cost effective data.

  

netFormulary